Source Bioscience
Source LDPath Wins 2023 MedTech Breakthrough Award
Nottingham, UK– May 3, 2023 – Source LDPath, a part of the Source BioScience Group, has been selected as the winner of the “Best Hospital Technology Implementation” award in the 7th annual MedTe...
Leading UK Diagnostics Provider Source LDPath Expands AI Capabilities with Ibex Medical Analytics
NHS Trusts Gain Access to Galen, Ibex’s Multi-tissue AI Platform, Supporting Pathologists with Enhanced Diagnostic Accuracy and Efficiency Source LDPath, a part of Source BioScience (Source), a ...
Groundbreaking digital approach helps cut pathology waiting times
London, 27 June 2022 – An innovative partnership between East Kent Hospitals and digital pathology company Source LDPath, a part of SourceBio International plc, is helping to reduce pathology wa...
Source BioScience completes £18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms
Source BioScience completes £18.5m strategic acquisition of LDPath Ltd Completes £18.5m strategic acquisition of LDPath Ltd Creates the largest and most technically advanced private provider o...